Loading interface...

Walasa 400 mg Tablet

Manufactured byWallace Pharmaceuticals Ltd.
ContainsMesalazine
Description
Walasa 400 mg Tablet is an anti-inflammatory medicine used for the treatment of ulcerative colitis, a condition characterized by swelling and scarring of the colon and rectum. It is also used to control the symptoms of ulcerative colitis such as stomach pain, diarrhea, and rectal bleeding.

Side effects

Major & minor side effects for Walasa 400 mg Tablet

  • Blurred vision
  • Nausea and vomiting
  • Headache
  • Dizziness
  • Hair loss
  • Constipation
  • Dry mouth
  • Increased sweating

Uses of Walasa 400 mg Tablet

What is it prescribed for?

  • Ulcerative Colitis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required by this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired side effects is necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to mesalazine or any other components present along with the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired side effects is necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Use in elderly population

Caution is advised while using this medicine in elderly patients due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Use of nonsteroidal anti-inflammatory drug (NSAIDs)

The use of NSAIDs along with this medicine may increase the risk of kidney impairment. Replacement with a suitable alternative should be considered under your doctor's supervision. It is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine to avoid such interactions.

Active peptic ulcer disease

This medicine should be used with caution in patients with active peptic ulcer disease due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Use in children

This medicine is not recommended for use in children under 6 years of age since safety and efficacy are not clinically established.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Tacrolimus

Adefovir

Deferasirox

Sirolimus

Botulism immune globulin

Disease interactions

Impaired liver function

This medicine should be used with extreme caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function levels may be necessary for such patients while taking this medicine. Appropriate dose adjustment or replacement with a suitable alternative may be required based on the clinical condition.

Kidney impairment

This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine reduces the symptoms of ulcerative colitis and prevents the worsening of symptoms by blocking the production of certain natural substances in the colon and rectum.
Legal Status

Approved

Unknown

Approved

Approved

Classification

Category

Anti-inflammatory agents, Bowel specific anti-inflammatory aminosalicylate

Schedule

Schedule H

Mesalamine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 8 June 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a688021.html

Mesalazine - DrugBank [Internet]. Drugbank.ca. 2020 [cited 8 June 2020]. Available from:

https://www.drugbank.ca/drugs/DB00244

DailyMed - Mesalazine tablet, delayed release [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 8 June 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e3b6325-a5bf-4c47-931c-142c0e4d7c3a

Zintasa 400mg Tablets - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2020 [cited 8 June 2020]. Available from:

https://www.medicines.org.uk/emc/product/10953/smpc

Search results detail| Kusurino-Shiori(Drug information Sheet) [Internet]. Rad-ar.or.jp. 2020 [cited 2 July 2020]. Available from:

https://www.rad-ar.or.jp/siori/english/kekka.cgi?n=1679
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 2 Jul 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.